HGTDR: Advancing drug repurposing with heterogeneous graph transformers

被引:13
作者
Gharizadeh, Ali [1 ]
Abbasi, Karim [1 ]
Ghareyazi, Amin [1 ]
Mofrad, Mohammad R. K. [2 ,3 ]
Rabiee, Hamid R. [1 ]
机构
[1] Sharif Univ Technol, Dept Comp Engn, POB 11155-9517, Tehran, Iran
[2] Univ Calif Berkeley, Dept Bioengn, POB 94720-1740, Berkeley, CA 94720 USA
[3] Univ Calif Berkeley, Dept Mech Engn, POB 94720-1740, Berkeley, CA 94720 USA
基金
美国国家科学基金会;
关键词
POLYMORPHISM; EFFICACY;
D O I
10.1093/bioinformatics/btae349
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Motivation Drug repurposing is a viable solution for reducing the time and cost associated with drug development. However, thus far, the proposed drug repurposing approaches still need to meet expectations. Therefore, it is crucial to offer a systematic approach for drug repurposing to achieve cost savings and enhance human lives. In recent years, using biological network-based methods for drug repurposing has generated promising results. Nevertheless, these methods have limitations. Primarily, the scope of these methods is generally limited concerning the size and variety of data they can effectively handle. Another issue arises from the treatment of heterogeneous data, which needs to be addressed or converted into homogeneous data, leading to a loss of information. A significant drawback is that most of these approaches lack end-to-end functionality, necessitating manual implementation and expert knowledge in certain stages.Results We propose a new solution, Heterogeneous Graph Transformer for Drug Repurposing (HGTDR), to address the challenges associated with drug repurposing. HGTDR is a three-step approach for knowledge graph-based drug repurposing: (1) constructing a heterogeneous knowledge graph, (2) utilizing a heterogeneous graph transformer network, and (3) computing relationship scores using a fully connected network. By leveraging HGTDR, users gain the ability to manipulate input graphs, extract information from diverse entities, and obtain their desired output. In the evaluation step, we demonstrate that HGTDR performs comparably to previous methods. Furthermore, we review medical studies to validate our method's top 10 drug repurposing suggestions, which have exhibited promising results. We also demonstrated HGTDR's capability to predict other types of relations through numerical and experimental validation, such as drug-protein and disease-protein inter-relations.Availability and implementation The source code and data are available at https://github.com/bcb-sut/HGTDR and http://git.dml.ir/BCB/HGTDR
引用
收藏
页数:11
相关论文
共 46 条
[21]   A real-time fluorescence assay for measuring N-dealkylation [J].
Mayer, Richard T. ;
Dolence, E. Kurt ;
Mayer, Gabriele E. .
DRUG METABOLISM AND DISPOSITION, 2007, 35 (01) :103-109
[22]  
Ng A., 2011, CS294A Lecture notes, V2011, P1
[23]   Deep learning for drug repurposing: Methods, databases, and applications [J].
Pan, Xiaoqin ;
Lin, Xuan ;
Cao, Dongsheng ;
Zeng, Xiangxiang ;
Yu, Philip S. ;
He, Lifang ;
Nussinov, Ruth ;
Cheng, Feixiong .
WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE, 2022, 12 (04)
[24]   Efficacy and tolerability of escitalopram in anxiety disorders: A review [J].
Pelissolo, A. .
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2008, 34 (04) :400-408
[25]   A global network of biomedical relationships derived from text [J].
Percha, Bethany ;
Altman, Russ B. .
BIOINFORMATICS, 2018, 34 (15) :2614-2624
[26]   Drug repurposing: progress, challenges and recommendations [J].
Pushpakom, Sudeep ;
Iorio, Francesco ;
Eyers, Patrick A. ;
Escott, K. Jane ;
Hopper, Shirley ;
Wells, Andrew ;
Doig, Andrew ;
Guilliams, Tim ;
Latimer, Joanna ;
McNamee, Christine ;
Norris, Alan ;
Sanseau, Philippe ;
Cavalla, David ;
Pirmohamed, Munir .
NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (01) :41-58
[27]  
Shimoni Z, 2007, ISRAEL MED ASSOC J, V9, P537
[28]   Drug repurposing approach to fight COVID-19 [J].
Singh, Thakur Uttam ;
Parida, Subhashree ;
Lingaraju, Madhu Cholenahalli ;
Kesavan, Manickam ;
Kumar, Dinesh ;
Singh, Raj Kumar .
PHARMACOLOGICAL REPORTS, 2020, 72 (06) :1479-1508
[29]   Vinorelbine, Paclitaxel, Etoposide, Cisplatin, and Cytarabine (VTEPA) Is an Effective Second Salvage Therapy for Relapsed/Refractory Hodgkin Lymphoma [J].
Sinha, Rajni ;
Shenoy, Pareen J. ;
King, Nassoma ;
Lechowicz, Mary Jo ;
Bumpers, Kevin ;
Hutcherson, Donald ;
Arellano, Martha ;
Langston, Amelia ;
Kaufman, Jonathan ;
Heffner, Leonard T., Jr. ;
Waller, Edmund K. ;
Nooka, Ajay ;
Flowers, Christopher R. ;
Lonial, Sagar .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (06) :657-663
[30]   Genetic Polymorphisms Associated With Constipation and Anticholinergic Symptoms in Patients Receiving Clozapine [J].
Solismaa, Anssi ;
Kampman, Olli ;
Lyytikainen, Leo-Pekka ;
Seppala, Niko ;
Viikki, Merja ;
Mononen, Nina ;
Lehtimaki, Terho ;
Leinonen, Esa .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2018, 38 (03) :193-199